Administration of Nanovaccines by Transdermal Drug Delivery System-current and Future Perspectives

被引：0

作者：

Shaik, Neelufar Shama ^{[1
]}

Firoz, Shaik ^{[2
]}

Peluri, Kalyani ^{[3
]}

Srikanth, M. S. ^{[4
]}

Gandupally, Naveen Kumar ^{[5
]}

机构：

[1] Scient Inst Pharm, Dept Pharmacognosy, Ibrahimpatnam, Telangana, India

[2] Sri Venkateswara Pharm Coll, Dept Pharmaceut, Chittoor, Andhra Prades, India

[3] Vydehi Inst Pharm, Dept Pharmaceut Anal, Bengaluru, Karnataka, India

[4] Mohan Babu Univ, MB Sch Pharmaceut Sci, Dept Pharmaceut, Tirupati, Andhra Prades, India

[5] Sri Venkateswara Coll Pharm, Dept Pharmacol, Chittoor, Andhra Prades, India

来源：

ASIAN JOURNAL OF PHARMACEUTICS | 2024年 / 18卷 / 02期

关键词：

Immune response; lipid-based nanocarriers; nanovaccines; transdermal drug delivery; VACCINE DELIVERY; NANOPARTICLES;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Nanovaccines have emerged as a promising approach to enhance vaccination strategies, leveraging the power of nanotechnology to improve immune responses and vaccine efficacy. In recent years, the administration of nanovaccines through transdermal drug delivery systems has garnered significant attention. This review explores the research examples highlighting the utilization of transdermal drug delivery systems for nanovaccine administration. It discusses various nanovaccine delivery approaches, such as microneedle patches and lipidbased nanocarriers, and presents research studies demonstrating their efficacy and potential in immunization.

引用

页码：337 / 345

页数：9

共 50 条

[1] Transdermal patches: Design and current approaches to painless drug delivery [J].

Al Hanbali, Othman A. ;

Khan, Haji Muhammad Shoaib ;

Sarfraz, Muhammad ;

Arafat, Mosab ;

Ijaz, Shakeel ;

Hameed, Abdul .

ACTA PHARMACEUTICA, 2019, 69 (02) :197-215

[2]

Ali A, 2018, Insights Biomed, V3, P15

[3]

Ali H, 2017, MOJ Bioequiv, V3, P47, DOI DOI 10.15406/MOJBB.2017.03.00031

[4] Towards tailored vaccine delivery: Needs, challenges and perspectives [J].

Amorij, Jean-Pierre ;

Kersten, Gideon F. A. ;

Saluja, Vinay ;

Tonnis, Wouter F. ;

Hinrichs, Wouter L. J. ;

Slutter, Bram ;

Bal, Suzanne M. ;

Bouwstra, Joke A. ;

Huckriede, Anke ;

Jiskoot, Wim .

JOURNAL OF CONTROLLED RELEASE, 2012, 161 (02) :363-376

[5] Intanza®: a new intradermal vaccine for seasonal influenza [J].

Atmar, Robert L. ;

Patel, Shital M. ;

Keitel, Wendy A. .

EXPERT REVIEW OF VACCINES, 2010, 9 (12) :1399-1409

[6] Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns [J].

Bachmann, Martin F. ;

Jennings, Gary T. .

NATURE REVIEWS IMMUNOLOGY, 2010, 10 (11) :787-796

[7] Topical and Transdermal Drug Delivery: From Simple Potions to Smart Technologies [J].

Benson, Heather A. E. ;

Grice, Jeffrey E. ;

Mohammed, Yousuf ;

Namjoshi, Sarika ;

Roberts, Michael S. .

CURRENT DRUG DELIVERY, 2019, 16 (05) :444-460

[8] Novel nanoparticles for the delivery of recombinant hepatitis B vaccine [J].

Bharali, Dhruba J. ;

Pradhan, Vandana ;

Elkin, Galina ;

Qi, Wu ;

Hutson, Alan ;

Mousa, Shaker A. ;

Thanavala, Yasmin .

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2008, 4 (04) :311-317

[9]

Bhowmik D, 2012, PHARMA INNOV, V1, P9

[10] Biomedical nanoparticles modulate specific CD4+ T cell stimulation by inhibition of antigen processing in dendritic cells [J].

Blank, Fabian ;

Gerber, Peter ;

Rothen-Rutishauser, Barbara ;

Sakulkhu, Usawadee ;

Salaklang, Jatuporn ;

De Peyer, Karin ;

Gehr, Peter ;

Nicod, Laurent P. ;

Hofmann, Heinrich ;

Geiser, Thomas ;

Petri-Fink, Alke ;

Von Garnier, Christophe .

NANOTOXICOLOGY, 2011, 5 (04) :606-621

← 1 2 3 4 5 →